Quantum Genome Governance

Introduction

Quantum Genome Governance is a proposed legal and ethical framework for supervising the use of quantum computing in genomic research, genetic testing, precision medicine, and gene editing. It is not an established standalone legal doctrine. It concerns how governments, research institutions, laboratories, biotechnology companies and healthcare providers should manage the opportunities and risks created by increasingly powerful genomic technologies.

Quantum computing may assist in analysing complex genetic datasets and modelling biological interactions. However, genomic information can reveal highly personal details about health, inherited traits and biological relationships. Errors, unauthorised disclosure, discriminatory use or unsafe genetic interventions may therefore affect both individuals and society.

The central objective of quantum genome governance is to ensure that scientific innovation remains consistent with human dignity, privacy, informed consent, public safety and accountability.

Principles of Quantum Genome Governance

The framework should be based on the following principles:

Privacy and data protection: Genomic data should be collected and processed only for lawful purposes, with appropriate safeguards.

Informed consent: Individuals must understand the purpose, risks and foreseeable uses of genetic testing or research.

Scientific validation: Quantum-assisted genomic systems should be independently tested and evaluated for reliability, bias and uncertainty.

Biosafety: Gene-editing research and environmental release must be subject to appropriate risk assessment and regulatory approval.

Accountability: Institutions should clearly assign responsibility for data misuse, inaccurate results, negligent research and unsafe interventions.

Equitable access: Genomic advances should not deepen discrimination or unjustly exclude disadvantaged communities.

In India, the Environment (Protection) Act, 1986 and the Rules of 1989 regulate specified activities involving genetically engineered organisms. The Digital Personal Data Protection Act, 2023 may apply to digital genomic data where its provisions are in force and applicable. These laws operate alongside constitutional protections and medical-research ethics.

Important Case Laws

1. Justice K.S. Puttaswamy (Retd.) v. Union of India (2017) 10 SCC 1

The Supreme Court recognised privacy as a fundamental right, including informational privacy and personal autonomy. Genomic information may reveal hereditary conditions, health risks and biological relationships. The judgment supports safeguards against unlawful or disproportionate collection and disclosure of genetic information.

Indian Kanoon

2. Samira Kohli v. Dr. Prabha Manchanda (2008) 2 SCC 1

The Supreme Court explained that valid medical consent must be voluntary and based on adequate information. This principle is relevant to genomic testing and research, where participants should understand the procedure, its purpose, foreseeable risks and potential uses of their biological samples.

3. Aruna Rodrigues v. Union of India (2012)

The Supreme Court considered concerns about biosafety and the environmental release of genetically modified organisms. The proceedings emphasised the importance of scientific assessment and regulatory oversight before environmental release. The case provides a relevant foundation for governance of gene-editing technologies, though it did not specifically concern quantum computing.

Indian Kanoon

4. Gene Campaign v. Union of India (2024 INSC 545)

The Supreme Court examined regulatory approval for the genetically modified mustard hybrid DMH-11. The judgment addressed biosafety, judicial review and the need for a national policy developed through stakeholder consultation. It illustrates the importance of transparent, scientifically grounded governance of genetic technologies. The case does not establish a specific legal regime for quantum-assisted genomics.

VoxJuris

Conclusion

Quantum Genome Governance aims to ensure that advanced genomic technologies are developed and used responsibly. Although it is not a recognised standalone doctrine, constitutional privacy, informed consent, biosafety regulation and judicial review provide a legal foundation for its development. Effective governance requires scientific validation, transparent decision-making, protection of genetic information, and clear accountability for harm.